Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion

Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1

(2018) M. Apfelbeck et al.   CLINICAL HEMORHEOLOGY AND MICROCIRCULATION

Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity–focused ultrasound focal therapy for localized prostate cancer

(2017) Louise Dickinson et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project

(2015) B. G. Muller et al.   WORLD JOURNAL OF UROLOGY

Focal Therapy in Prostate Cancer: International Multidisciplinary Consensus on Trial Design

(2014) Willemien van den Bos et al.   EUROPEAN UROLOGY

Active Surveillance, Quality of Life, and Cancer-related Anxiety

(2013) Laurence Klotz   EUROPEAN UROLOGY

Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner?

(2009) Walter R Parker et al.   CURRENT OPINION IN UROLOGY

Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI

(2009) Olivier Rouvière et al.   EUROPEAN RADIOLOGY

MR Imaging of Prostate after Treatment with High-Intensity Focused Ultrasound

(2008) Alexander P. S. Kirkham et al.   RADIOLOGY

High-risk prostate cancer in the United States, 1990–2007

(2008) Matthew R. Cooperberg et al.   WORLD JOURNAL OF UROLOGY